A Comparaitive Study between 25 Mcg Dexmedetomidine and 25 Mcg Clonidine as Adjuvant with 0.5% Levobupivacaine in Supraclavicular Brachial Plexus Block in Upper Limb Surgeries
Authors/Creators
- 1. Associate Professor, Department of Anesthesia, Rangaraya Medical College, Kakinada.
- 2. Assistant Professor, Department of Anesthesia, Rangaraya Medical College, Kakinada.
Description
Introduction: This study compares the efficacy and safety of dexmedetomidine and clonidine as adjuvants to levobupivacaine in supraclavicular brachial plexus block for upper limb surgeries. Dexmedetomidine’s higher selectivity for α2-adrenergic receptors potentially enhances its analgesic effects compared to clonidine. Methods: A prospective study conducted at Rangaraya Medical College, Kakinada, evaluated ASA grade I and II patients, aged 18-50, undergoing upper limb surgeries. groups C and D received clonidine and dexmedetomidine, respectively, with levobupivacaine in supraclavicular blocks. Sensory and motor block characteristics were assessed post-operatively for 24 hours. Results: Group D exhibited faster onset of sensory and motor blocks (4.86 ± 0.91 mins and 7.08 ± 1.006 mins) compared to group C (7.2 ± 1.1 mins and 9.94 ± 1.67 mins). Motor block duration was longer in group D (12.7 ± 0.7 hrs) than group C (10.8 ± 0.6 hrs). Rescue analgesic requirement and sedation scores significantly varied between groups. Conclusions: Dexmedetomidine as an adjuvant to levobupivacaine in brachial plexus block demonstrated faster onset of sensory and motor blocks, prolonged motor block duration, and reduced rescue analgesic requirement compared to clonidine. These findings suggest dexmedetomidine’s potential superiority in enhancing regional anesthesia outcomes for upper limb surgeries.
Abstract (English)
Introduction: This study compares the efficacy and safety of dexmedetomidine and clonidine as adjuvants to levobupivacaine in supraclavicular brachial plexus block for upper limb surgeries. Dexmedetomidine’s higher selectivity for α2-adrenergic receptors potentially enhances its analgesic effects compared to clonidine. Methods: A prospective study conducted at Rangaraya Medical College, Kakinada, evaluated ASA grade I and II patients, aged 18-50, undergoing upper limb surgeries. groups C and D received clonidine and dexmedetomidine, respectively, with levobupivacaine in supraclavicular blocks. Sensory and motor block characteristics were assessed post-operatively for 24 hours. Results: Group D exhibited faster onset of sensory and motor blocks (4.86 ± 0.91 mins and 7.08 ± 1.006 mins) compared to group C (7.2 ± 1.1 mins and 9.94 ± 1.67 mins). Motor block duration was longer in group D (12.7 ± 0.7 hrs) than group C (10.8 ± 0.6 hrs). Rescue analgesic requirement and sedation scores significantly varied between groups. Conclusions: Dexmedetomidine as an adjuvant to levobupivacaine in brachial plexus block demonstrated faster onset of sensory and motor blocks, prolonged motor block duration, and reduced rescue analgesic requirement compared to clonidine. These findings suggest dexmedetomidine’s potential superiority in enhancing regional anesthesia outcomes for upper limb surgeries.
Files
IJTPR,Vol14,Issue6,Article10.pdf
Files
(298.5 kB)
| Name | Size | Download all |
|---|---|---|
|
md5:8fce0451cd1e930068c74f34532480f8
|
298.5 kB | Preview Download |
Additional details
Dates
- Accepted
-
2024-05-25
Software
References
- 1. Agarwal S, Aggarwal R, Gupta P. Dexmedetomidine prolongs the effect of bupivacaine in supraclavicular brachial plexus block. Journal of Anaesthesiology Clinical Pharmacology. 2014; 30(1): 36 – 40. 2. Esmaoglu A, Yegenoglu F, Akin A, Turk CY. Dexmedetomidine added to levobupivacaine prolongs axillary brachial plexus block. Anaesthesia and Intensive Care. 2010;38(4):647–52. 3. Singh S, Aggarwal A. A randomised controlled trial to evaluate the efficacy of clonidine as an adjuvant to bupivacaine in brachial plexus block. Indian Journal of Anaesthesia. 2010; 54(6): 552 – 7. 4. Kumar R, Tripathi S. Comparative study between clonidine and dexmedetomidine as an adjuvant to bupivacaine in supraclavicular brachial plexus block. Journal of Anaesthesia and Clinical Research. 2014; 5(2): 403 – 8. 5. Esmaoglu A, Yegenoglu F, Akin A, Turk CY. Dexmedetomidine added to levobupivacaine prolongs axillary brachial plexus block. Anaesthesia and Intensive Care. 2010; 38(4): 647 – 52. 6. Agarwal S, Aggarwal R, Gupta P. Dexmedetomidine prolongs the effect of bupivacaine in supraclavicular brachial plexus block. Journal of Anaesthesiology Clinical Pharmacology. 2014; 30(1): 36 – 40. 7. Singh S, Aggarwal A. A randomised controlled trial to evaluate the efficacy of clonidine as an adjuvant to bupivacaine in brachial plexus block. Indian Journal of Anaesthesia. 2010; 54(6): 552 – 7. 8. Singla D, Mangla M, Aggarwal A, Gupta A. Dexmedetomidine as an adjuvant to ropivacaine in supraclavicular brachial plexus block. Journal of Anaesthesiology Clinical Pharmacology. 2015; 31(3): 333 – 7. 9. Abdelhamid AM, El-lakany MH. Clonidine as adjuvant to local anesthetic mixture for brachial plexus block. Egyptian Journal of Anaesthesia. 2014; 30(4): 421 – 6. 10. Abdallah FW, Brull R. Facilitatory effects of perineural dexmedetomidine on neuraxial and peripheral nerve block: a systematic review and meta-analysis. British Journal of Anaesthesia. 2013; 110(6): 915 – 25. 11. El-Rahmawy GF, Fawzy MA, Marey HS, et al. Dexmedetomidine versus clonidine as an adjuvant to bupivacaine for caudal analgesia in pediatric cancer patients undergoing lower abdominal surgeries. Pain Physician. 2016; 19(2) : E255 – 63.